Phase IB/II of CPX-351 for Relapse Prevention in AML

Clinical trial NCT04990102 · RECRUITING

Trial details

NCT number: NCT04990102
Sponsor: Georgetown University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML) in Remission

Start date: 2023-05-22
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.